TCL Archive FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer July 27, 2012
TCL Archive FDA Approved 88% Of Cancer Applications Since Oncology Office Opened In 2005. July 3, 2008
TCL Archive Cancer Program Advocates, Success Overcame Powerful Negative Factors To Win Budget Fight August 10, 1979